UB Paderborn / Katalog / Suche / in CDI

Trends in patient‐reported outcome use in early phase dose‐finding oncology trials – an analysis of ClinicalTrials.gov

Cancer medicine (Malden, MA), 2021-11, Vol.10 (22), p.7943-7957

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of common clinical problems experienced by survivors of cancer

The Lancet (British edition), 2022-04, Vol.399 (10334), p.1537-1550

2022

Link zum Volltext

Verfügbarkeit prüfen

Assessing the Clinical Utility of Computed Tomography‐Based Radiomics

The oncologist (Dayton, Ohio), 2018-07, Vol.23 (7), p.747-749

2018

Link zum Volltext

Verfügbarkeit prüfen

Which patients with dermatological conditions are admitted via the emergency department?

Australasian journal of dermatology, 2014-11, Vol.55 (4), p.255-259

2014

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapies for unresectable locoregional melanoma: a significant area of need

Melanoma management, 2019-11, Vol.6 (3), p.MMT25-MMT25

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Managing Cancer and Living Meaningfully (CALM) in people with advanced non-small cell lung cancer treated with immunotherapies or targeted therapies: protocol for a single-arm, mixed-methods pilot study

BMJ open, 2023-07, Vol.13 (7), p.e072322-e072322

2023

Link zum Volltext

Verfügbarkeit prüfen

Designing a wholly online, multidisciplinary Master of Cancer Sciences degree

BMC medical education, 2023-07, Vol.23 (1), p.544-544, Article 544

2023

Link zum Volltext

Verfügbarkeit prüfen

Embedding electronic patient-reported outcome measures into routine care for patients with stage III MELanoma (ePROMs-MEL): protocol for a prospective, longitudinal, mixed-methods pilot study

BMJ open, 2022-12, Vol.12 (12), p.e066852-e066852

2022

Link zum Volltext

Verfügbarkeit prüfen

Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)

BMJ open, 2021-09, Vol.11 (9), p.e049217-e049217

2021

Link zum Volltext

Verfügbarkeit prüfen

Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma

Journal of clinical medicine, 2020-09, Vol.9 (9), p.2969

2020

Link zum Volltext

Verfügbarkeit prüfen

Implementing novel models of posttreatment care for cancer survivors: Enablers, challenges and recommendations

Asia-Pacific journal of clinical oncology, 2015-12, Vol.11 (4), p.319-327

2015

Link zum Volltext

Verfügbarkeit prüfen

Unsuspected allergic contact dermatitis to alcohol swabs following neurosurgery

Australasian journal of dermatology, 2014-11, Vol.55 (4), p.296-298

2014

Link zum Volltext

Verfügbarkeit prüfen

In reply to: 'Study key words are inclusion criteria and should be shared for interpretation'

Australasian journal of dermatology, 2015-05, Vol.56 (2), p.139-141

2015

Link zum Volltext

Verfügbarkeit prüfen

Which Dermatological Conditions Present to an Emergency Department in Australia?

Emergency Medicine International, 2014-01, Vol.2014 (2014), p.463026-4

2014

Link zum Volltext

Verfügbarkeit prüfen

Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy

European journal of cancer (1990), 2024-03, Vol.200, p.113601-113601, Article 113601

2024

Link zum Volltext

Verfügbarkeit prüfen

International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire

International journal of radiation oncology, biology, physics, 2023-04, Vol.115 (5), p.1155-1164

2023

Link zum Volltext

Verfügbarkeit prüfen

Common toxicities associated with immune checkpoint inhibitors and targeted therapy in the treatment of melanoma: A systematic scoping review

Critical reviews in oncology/hematology, 2023-03, Vol.183, p.103919-103919, Article 103919

2023

Link zum Volltext

Verfügbarkeit prüfen

Entanglements and imagined futures: The subject(s) of precision in oncology

Social science & medicine (1982), 2023-01, Vol.317, p.115608-115608, Article 115608

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review

European journal of cancer (1990), 2023-05, Vol.184, p.83-105

2023

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review [European Journal of Cancer 184 (2023) 83–105]

European journal of cancer (1990), 2023-09, Vol.190, p.112937-112937, Article 112937

2023

Link zum Volltext

Verfügbarkeit prüfen

Evolving Landscape of Metastatic Cancer Survivorship: Reconsidering Clinical Care, Policy, and Research Priorities for the Modern Era

Journal of clinical oncology, 2023-06, Vol.41 (18), p.3304-3310

2023

Link zum Volltext

Verfügbarkeit prüfen

Moving beyond epidermal growth factor receptor resistance in metastatic non-small cell lung cancer - a drug development perspective

Critical reviews in oncology/hematology, 2021-03, Vol.159, p.103225-103225, Article 103225

2021

Link zum Volltext

Verfügbarkeit prüfen

Surviving metastatic non-small cell lung cancer (mNSCLC): The lived experience and supportive care needs of patients (pts) receiving immunotherapy (IT) or targeted therapy (TT)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e24185-e24185

2020

Link zum Volltext

Verfügbarkeit prüfen

Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum

The oncologist (Dayton, Ohio), 2022-09, Vol.27 (9), p.768-777

2022

Link zum Volltext

Verfügbarkeit prüfen

What matters most to people with metastatic uveal melanoma? A qualitative study to inform future measurement of health-related quality of life

Melanoma research, 2024-06, Vol.34 (3), p.248

2024

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Trends in patient‐reported outcome use in early phase dose‐finding oncology trials – an analysis of ClinicalTrials.gov

Management of common clinical problems experienced by survivors of cancer

Assessing the Clinical Utility of Computed Tomography‐Based Radiomics

Which patients with dermatological conditions are admitted via the emergency department?

Systemic therapies for unresectable locoregional melanoma: a significant area of need

Evaluation of Managing Cancer and Living Meaningfully (CALM) in people with advanced non-small cell lung cancer treated with immunotherapies or targeted therapies: protocol for a single-arm, mixed-methods pilot study

Designing a wholly online, multidisciplinary Master of Cancer Sciences degree

Embedding electronic patient-reported outcome measures into routine care for patients with stage III MELanoma (ePROMs-MEL): protocol for a prospective, longitudinal, mixed-methods pilot study

Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)

Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma

Implementing novel models of posttreatment care for cancer survivors: Enablers, challenges and recommendations

Unsuspected allergic contact dermatitis to alcohol swabs following neurosurgery

In reply to: 'Study key words are inclusion criteria and should be shared for interpretation'

Which Dermatological Conditions Present to an Emergency Department in Australia?

Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy

International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire

Common toxicities associated with immune checkpoint inhibitors and targeted therapy in the treatment of melanoma: A systematic scoping review

Entanglements and imagined futures: The subject(s) of precision in oncology

Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review

Corrigendum to ‘Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review [European Journal of Cancer 184 (2023) 83–105]

Evolving Landscape of Metastatic Cancer Survivorship: Reconsidering Clinical Care, Policy, and Research Priorities for the Modern Era

Moving beyond epidermal growth factor receptor resistance in metastatic non-small cell lung cancer - a drug development perspective

Surviving metastatic non-small cell lung cancer (mNSCLC): The lived experience and supportive care needs of patients (pts) receiving immunotherapy (IT) or targeted therapy (TT)

Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum

What matters most to people with metastatic uveal melanoma? A qualitative study to inform future measurement of health-related quality of life

Suchergebnisse filtern